"To date, only Cynata has the capablility of providing a demonstrably safe scaleable product for use in medicinal grade therapies. "
Sorry to intrude, however this is wrong. MSB has been doing this for several years and most probably be filling for approval with the FDA this year. As for safety it is my understanding that MSB has had no issues despite several thousand people been treated.
Anyway on something different, can anyone explain why CYP and MSB make significant announcements at the same time, it's like we have a partnership with each other.
Good luck to everyone.
Ann: Cynata GvHD Trial Meets all Safety & Efficacy Endpoints, page-33
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
21.0¢ |
Change
-0.005(2.33%) |
Mkt cap ! $37.91M | |||
| Open | High | Low | Value | Volume |
| 21.0¢ | 21.0¢ | 20.5¢ | $11.26K | 53.68K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 7339 | 20.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 22.5¢ | 32225 | 2 |
View Market Depth
| Last trade - 15.39pm 23/08/2024 (20 minute delay) ? |
| CYP (ASX) Chart |